<SEC-DOCUMENT>0001213900-25-032642-index.html : 20250416 <SEC-HEADER>0001213900-25-032642.hdr.sgml : 20250416 <ACCEPTANCE-DATETIME>20250416171552 ACCESSION NUMBER: 0001213900-25-032642 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20250416 FILED AS OF DATE: 20250416 DATE AS OF CHANGE: 20250416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AKANDA CORP. CENTRAL INDEX KEY: 0001888014 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41324 FILM NUMBER: 25843576 BUSINESS ADDRESS: STREET 1: 1A, 1B LEAROYD ROAD CITY: NEW ROMNEY STATE: X0 ZIP: TN28 8XU BUSINESS PHONE: 442034889514 MAIL ADDRESS: STREET 1: 77 KING STREET WEST, SUITE 400 STREET 2: C/O DENTONS CANADA LLP CITY: TORONTO STATE: A6 ZIP: M5K 0A1 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>ea0238464-6k_akanda.htm <DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER <TEXT> Document 1 - file: ea0238464-6k_akanda.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ea023846401ex99-1_akanda.htm <DESCRIPTION>NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF THE SHAREHOLDERS OF AKANDA CORP. WHICH IS SCHEDULED TO BE HELD ON APRIL 30, 2025, AND MANAGEMENT INFORMATION CIRCULAR <TEXT> Document 2 - file: ea023846401ex99-1_akanda.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>ea023846401ex99-2_akanda.htm <DESCRIPTION>PROXY CARD <TEXT> Document 3 - file: ea023846401ex99-2_akanda.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>ex99-1_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: ex99-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>ex99-2_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: ex99-2_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>ex99-2_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: ex99-2_002.jpg
</DOCUMENT> </SEC-DOCUMENT>